IP Library Granted Patent US 11,982,679
Granted Patent B2
US 11,982,679 · App. 16/464,197 · Granted May 14, 2024

Conformational mimotopes for detecting specific antibodies

Inventors: Salvatore Guglielmino (Catania, IT); Laura Maria De Plano (Catania, IT); Santina Carnazza (Catania, IT); Domenico Franco (Catania, IT); Alessandra Nicoletti (Catania, IT); Mario Zappia (Catania, IT); Sabrina Conoci (Catania, IT); Salvatore Petralia (Catania, IT)
Assignee: DISTRETTO TECNOLOGICO SICLILIA MICRO E NANO SISTEMI S.C.A.R.L.
G01N33/6896C07K7/08C12N15/1037G16B15/00G16B45/00G01N2333/4709G01N2800/2821
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,982,679
App. No.
16/464,197
Granted
May 14, 2024
Kind
B2
Abstract

The present invention relates to a method for obtaining protein mimotopes occurring in at least two distinct 3D conformations. In a further embodiment, a method for detecting antibodies with diagnostic relevance using said mimotopes is claimed. In a preferred embodiment, said methods are applied to Alzheimer's disease.

Claims (3)

1. A peptide comprising the amino acid sequence selected from the group comprising: NH2-RWPPHFEWHFDD-COOH (SEQ ID NO: 1), NH2-GGGCIEGPCLEG-COOH (SEQ ID NO: 4), and NH2-HRGCIEGPCLDA-COOH (SEQ ID NO: 5).

2. A method for diagnosing Alzheimer's disease (AD) in a subject comprising preparing a phage clone expressing a peptide comprising the amino acid sequence NH2-RWPPHFEWHFDD-COOH (SEQ ID NO: 1); exposing precipitate of said phage clone to a subject's serum; after suitable incubation and washings, incubating with an anti-human IgG antibody; detecting the results of reaction, wherein a positive result of the reaction is indicative of AD pathology.

3. A method for detecting an antibody in a sample comprising preparing a phage clone expressing a peptide of claim 1 ; exposing precipitate of said phage clone to the sample; after suitable incubation and washings, incubating with an anti-human IgG antibody; detecting the results of reaction, wherein a positive result of the reaction is indicative of antibodies in the sample that bind the peptide of claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2020
From: GUGLIELMINO, SALVATORE; DE PLANO, LAURA MARIA; CARNAZZA, SANTINA; FRANCO, DOMENICO; NICOLETTI, ALESSANDRA; ZAPPIA, MARIO; CONOCI, SABRINA; PETRALIA, SALVATORE
To: DISTRETTO TECNOLOGICO SICILIA MICRO E NANO SISTEMI S.C.A.R.L.
Reel/Frame 051746/0233 →
Priority Claims (1)
IT 102016000120204 · Nov 28, 2016 · national
Continuity (1)
Related Publication 20190383834A1 · Dec 19, 2019